Episode 27 - Nathan Clark and 10% Faster to the Market with Digitalization

My guest in this episode is Nathan Clark. Nathan is the Co-Founder of Ganymede.bio, one of the fastest-growing software startups in biotech. Ganymede is the modern, data platform for life sciences companies, and its focused on integrating physical lab instruments with digital workflows. Prior to Ganymede, Nathan was the product manager at Benchling for Machine Learning and Insights Analytics. He also has a background in financial technology and trading, and notably launched affirm.com/savings. In this informative talk, Nathan and I talked about - His journey from being a bond trader to a life science data entrepreneur, - Difference between Fintech and life science tech - How Genymede is doing it differently than the other companies - How to be 10% faster to the market with new drugs - Growing with a remote working team - Why he got into a life science start up - His fondness for MIT Open Courseware You can reach out to him by email, his website or LinkedIn. I enjoyed my chat with Nathan. Hope you do too.

You can listen to Episode 27 - Nathan Clark and 10% Faster to the Market with Digitalization online on Radio and Podcast. Open the player on this page to stream the available audio.

Episode 27 - Nathan Clark and 10% Faster to the Market with Digitalization is an episode from The Future of Pharma by Samir Gondalia, ISPE Boston.

This episode is 41:38 long.

This episode was published on Nov 21, 2024.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from The Future of Pharma when more episodes are available from the podcast feed.